Value Investing
Zydus Lifesciences and Torrent Pharma, with their respective focuses on innovation and strategic acquisitions, illustrate the multifaceted nature of competition in the pharmaceutical industry. Zydus’s investment in groundbreaking treatments like Rexigo positions it as a leader in healthcare innovation, while Torrent’s potential acquisition of Cipla underscores its ambitions for market expansion and consolidation.